Skip to content

PROTOCOLO ABAS

AMPICILLIN/BALSAMIC (A/B) VS PENICILLIN FENOXIMETILIC (PF) IN TREATMENT OF ACUTE STREPTOCOCCAL PHARYNGITIS (ASP)

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
REPEC
Registry ID
PER-023-14
Enrollment
60
Registered
2015-01-23
Start date
2014-04-15
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

When the research subject will be eligible, proceed to randomized and double-blind enrollment, samples of pharyngeal secretion and blood will be taken. Subjects will be enrolled to one of two study

Sponsors

Medifarma S.A.,
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Clinical diagnosis of FA: Congestion and pharyngeal secretion. Malaise, microbiological diagnosis of FAE, defined by: POSITIVE culture to Streptococcus, Age> 18 years old, ability to give informed consent, patients without antibiotic treatment (48 h before the inclusion) in relation to the screening visit (0 day - visit 1)

Exclusion criteria

Exclusion criteria: Acute pharyngitis without secretion, History of allergy to penicillins by anamnesis, use of antibiotics in the last 48 hours, renal failure with serum creatinine> 1.5 mg/dL or calculated clearance (using the Cockcroft-Gault) that suggest a renal function <60 ml / min, any other clinical condition that the investigator believes.

Countries

Peru

Contacts

Public ContactDANIEL HIROMOTO

Medifarma S.A.

dhiromoto@medifarma.com.pe012070000

Outcome results

None listed

Source: REPEC (via WHO ICTRP)